UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mechanism of Follicular Helper T Cell Differentiation Regulated by Transcription Factors

Journal of Immunology Research, 2020, Vol.2020 (2020), p.1-9

2020

Volltextzugriff (PDF)

Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway

International journal of biological sciences, 2022-01, Vol.18 (4), p.1594-1611

2022

Volltextzugriff (PDF)

Changes in patients’ symptoms and gastric emptying after Helicobacter pylori treatment

World journal of gastroenterology : WJG, 2016-05, Vol.22 (18), p.4585-4593

2016

Volltextzugriff (PDF)

Beneficial Effects of Bushen Formula Combined with Enticavir on Chronic Hepatitis B Patients with Suboptimal Response to Enticavir by Regulating B-Cell Differentiation

Cellular physiology and biochemistry, 2018-01, Vol.48 (2), p.633-643

2018

Volltextzugriff (PDF)

Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients

Journal of immunology research, 2019-01, Vol.2019 (2019), p.1-10

2019

Volltextzugriff (PDF)

Corrigendum to “Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients”

Journal of Immunology Research, 2022-01, Vol.2022, p.7931597-1

2022

Volltextzugriff (PDF)

Natural killer cells in hepatitis B virus infection

The Brazilian journal of infectious diseases, 2015-07, Vol.19 (4), p.417-425

2015

Volltextzugriff (PDF)

Bushen Jianpi Formula Combined with Entecavir for the Treatment of HBeAg-Negative Chronic Hepatitis B: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Evidence-based complementary and alternative medicine, 2022, Vol.2022, p.6097221-10

2022

Volltextzugriff (PDF)

Long-Term Traditional Chinese Medicine Combined with NA Antiviral Therapy on Cirrhosis Incidence in Chronic Hepatitis B Patients in the Real-World Setting: A Retrospective Study

Evidence-based complementary and alternative medicine, 2020, Vol.2020 (2020), p.1-8

2020

Volltextzugriff (PDF)

HBcAg induces PD-1 upregulation on CD4+T cells through activation of JNK, ERK and PI3K/AKT pathways in chronic hepatitis-B-infected patients

Laboratory investigation, 2012-02, Vol.92 (2), p.295-304

2012

Volltextzugriff (PDF)

Ganji Formulation for Patients with Hepatocellular Carcinoma Who Have Undergone Surgery: A Multicenter, Randomized, Double-Blind, Controlled Trial

Evidence-based complementary and alternative medicine, 2019, Vol.2019 (2019), p.1-6

2019

Volltextzugriff (PDF)

Utility and Safety of Tolvaptan in Cirrhotic Patients with Hyponatremia: a Prospective Cohort Study

Annals of hepatology, 2017-01, Vol.16 (1), p.123-132

2017

Volltextzugriff (PDF)

Therapeutic Efficacy of Fuzheng-Huayu Tablet Based Traditional Chinese Medicine Syndrome Differentiation on Hepatitis-B-Caused Cirrhosis : A Multicenter Double-Blind Randomized Controlled Trail

Evidence-based complementary and alternative medicine, 2013-01, Vol.2013 (2013), p.1-8

2013

Volltextzugriff (PDF)

Yin-chen Wu-ling powder alleviate cholestatic liver disease: Network pharmacological analysis and experimental validation

Gene, 2023-01, Vol.851, p.146973-146973, Article 146973

2023

Volltextzugriff (PDF)

Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial

Journal of ethnopharmacology, 2022-07, Vol.293, p.115210-115210, Article 115210

2022

Volltextzugriff (PDF)

Synthesis and biological evaluation of fluorinated 3,4-dihydroquinolin-2(1 H )-ones and 2-oxindoles for anti-hepatic fibrosis

RSC advances, 2021-02, Vol.11 (11), p.5923-5927

2021

Volltextzugriff (PDF)

High prevalence of the B2＋C2 subgenotype mixture in patients with chronic hepatitis B in Eastern China

Acta pharmacologica Sinica, 2012-10, Vol.33 (10), p.1271-1276

2012

Volltextzugriff (PDF)

Lingmao Formula Combined with Entecavir for HBeAg-Positive Chronic Hepatitis B Patients with Mildly Elevated Alanine Aminotransferase : A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Evidence-based complementary and alternative medicine, 2013-01, Vol.2013 (2013), p.1-7

2013

Volltextzugriff (PDF)

Cell cycle-related kinase mediates viral-host signalling to promote hepatitis B virus-associated hepatocarcinogenesis

Gut, 2014-11, Vol.63 (11), p.1793-1804

2014

Volltextzugriff (PDF)

Interleukin-10 Genotype Correlated to Deficiency Syndrome in Hepatitis B Cirrhosis

Evidence-based complementary and alternative medicine, 2012-01, Vol.2012 (2012), p.1-6

2012

Volltextzugriff (PDF)

C‐C chemokine hepatocellular carcinoma motif ligand 5‐deficiency promotes hepatocellular carcinoma progression by affecting B cell recruitment

Journal of digestive diseases, 2021-07, Vol.22 (7), p.433-441

2021

Volltextzugriff (PDF)

Hepatitis B core antigen upregulates B7-H1 on dendritic cells by activating the AKT/ERK/P38 pathway: a possible mechanism of hepatitis B virus persistence

Laboratory investigation, 2016-11, Vol.96 (11), p.1156-1164

2016

Volltextzugriff (PDF)

Traditional Chinese medicine in prevention and treatment of primary liver cancer: Research dilemmas and possible ways out

World Chinese Journal of Digestology, 2017, Vol.25 (25), p.2249

2017

Volltextzugriff (PDF)

Curative Effects of ZHENG-Based Fuzheng-Huayu Tablet on Hepatitis B Caused Cirrhosis Related to CYP1A2 Genetic Polymorphism

Evidence-based complementary and alternative medicine, 2013-01, Vol.2013 (2013), p.1-7

2013

Volltextzugriff (PDF)

Germacrone inhibits the proliferation of glioma cells by promoting apoptosis and inducing cell cycle arrest

Molecular medicine reports, 2014-08, Vol.10 (2), p.1046-1050

2014

Volltextzugriff (PDF)

1 – 25 von 266

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(223)

Publikationsform

Sprache

Englisch
(211)
Chinesisch
(57)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Mechanism of Follicular Helper T Cell Differentiation Regulated by Transcription Factors

Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway

Changes in patients’ symptoms and gastric emptying after Helicobacter pylori treatment

Beneficial Effects of Bushen Formula Combined with Enticavir on Chronic Hepatitis B Patients with Suboptimal Response to Enticavir by Regulating B-Cell Differentiation

Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients

Corrigendum to “Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients”

Natural killer cells in hepatitis B virus infection

Bushen Jianpi Formula Combined with Entecavir for the Treatment of HBeAg-Negative Chronic Hepatitis B: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Long-Term Traditional Chinese Medicine Combined with NA Antiviral Therapy on Cirrhosis Incidence in Chronic Hepatitis B Patients in the Real-World Setting: A Retrospective Study

HBcAg induces PD-1 upregulation on CD4+T cells through activation of JNK, ERK and PI3K/AKT pathways in chronic hepatitis-B-infected patients

Ganji Formulation for Patients with Hepatocellular Carcinoma Who Have Undergone Surgery: A Multicenter, Randomized, Double-Blind, Controlled Trial

Utility and Safety of Tolvaptan in Cirrhotic Patients with Hyponatremia: a Prospective Cohort Study

Therapeutic Efficacy of Fuzheng-Huayu Tablet Based Traditional Chinese Medicine Syndrome Differentiation on Hepatitis-B-Caused Cirrhosis : A Multicenter Double-Blind Randomized Controlled Trail

Yin-chen Wu-ling powder alleviate cholestatic liver disease: Network pharmacological analysis and experimental validation

Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trial

Synthesis and biological evaluation of fluorinated 3,4-dihydroquinolin-2(1 H )-ones and 2-oxindoles for anti-hepatic fibrosis

High prevalence of the B2＋C2 subgenotype mixture in patients with chronic hepatitis B in Eastern China

Lingmao Formula Combined with Entecavir for HBeAg-Positive Chronic Hepatitis B Patients with Mildly Elevated Alanine Aminotransferase : A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Cell cycle-related kinase mediates viral-host signalling to promote hepatitis B virus-associated hepatocarcinogenesis

Interleukin-10 Genotype Correlated to Deficiency Syndrome in Hepatitis B Cirrhosis

C‐C chemokine hepatocellular carcinoma motif ligand 5‐deficiency promotes hepatocellular carcinoma progression by affecting B cell recruitment

Hepatitis B core antigen upregulates B7-H1 on dendritic cells by activating the AKT/ERK/P38 pathway: a possible mechanism of hepatitis B virus persistence

Traditional Chinese medicine in prevention and treatment of primary liver cancer: Research dilemmas and possible ways out

Curative Effects of ZHENG-Based Fuzheng-Huayu Tablet on Hepatitis B Caused Cirrhosis Related to CYP1A2 Genetic Polymorphism

Germacrone inhibits the proliferation of glioma cells by promoting apoptosis and inducing cell cycle arrest

Suchergebnisse filtern